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Abstract 1 
 2 
 We previously reported that piperine, an active alkaloidal principal of black and 3 
long peppers, enhances drug bioavailability by inhibiting drug metabolism. Another 4 
mechanism influencing drug availability/uptake is its free fraction. Since piperine is 5 
highly lipophilic, we hypothesize that it could also interact with drugs through binding 6 
displacement and influence their bioavailability. Accordingly, using equilibrium dialysis, 7 
we investigated whether piperine alters the binding of model drug ligands i.e. 8 
flunitrazepam, diazepam, warfarin, salicylic acid, propranolol, lidocaine and 9 
disopyramide to human plasma (n=4). Since, alterations in binding influences drug 10 
disposition, we also studied the effects of piperine on the uptake of plasma bound 3H-11 
propranolol and 14C-warfarin by cultured bovine brain microvascular endothelial cells 12 
(BMECs). Piperine (1-1000µM) increased the free fraction (fu) of both albumin and 13 
alpha-acid glycoprotein (alpha-AGP) bound drugs in a concentration-dependent manner 14 
(P<0.01). Moreover, piperine (10µM) increased the uptake of 3H-propranolol and 14C-15 
warfarin by BMECs (P<.01). In conclusion, our findings provide the first evidence that 16 
piperine displaces plasma bound drugs from both albumin and alpha-AGP, and facilitates 17 
drug uptake across biological membranes (e.g. BMEC). Moreover, it is feasible, that 18 
piperine may similarly facilitate the transport of drugs into tissues, in vivo, and alter both 19 
pharmacokinetics and pharmacodynamics of administered drugs. 20 
21 
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Introduction:  1 
Drug action in the body depends on the rate of metabolism, blood flow, and extent 2 
of binding to plasma proteins (Dayton et al., 1973; Wilkinson and Shand, 1975; 3 
Wilkinson, 1987; Rowland and Tozer, 1980). Alterations in either characteristics can 4 
potentially effect the body distribution of the compound as well as its removal from the 5 
body, thereby modulating its pharmacological action (Dayton et al., 1973; Wilkinson and 6 
Shand, 1975; Wilkinson, 1987; Rowland and Tozer, 1980). Moreover, dietary molecules 7 
can influence the pharmacokinetics and pharmacodynamics of drugs by altering drug 8 
binding as well as metabolism (Melander, 1978).  Piperine (1-piperoyl piperidine) a major 9 
active ingredient of black and long peppers (Figure 1), which is widely used in foods and 10 
traditional systems of medicine has been shown to enhance bioavailability of drugs 11 
(Srinivasan 2007). For example, piperine increases the plasma concentrations of test 12 
drugs such as fexofenadine (Bedada and Boga, 2017; Jin and Han 2010), phenytoin (Bano 13 
et al., 1987), propranolol (Bano et al., 1991), theophylline (Bano et al., 1991), rifampicin 14 
(Zutshi et al., 1985), in humans. Earlier we suggested an explanation to this phenomenon 15 
based on the compound’s strong inhibitory effect on hepatic and intestinal drug 16 
metabolising enzymes (Atal et al., 1985; Reen et al., 1996) both in-vivo and in-vitro and 17 
offered it as the plausible explanation for the mechanism by which it could enhance drug 18 
bioavailability and hence prolong drug action. Although inhibition of the monoxygenases 19 
by certain compounds can enhance bioavailability of drugs (Sontaniemi, 1993) and alter 20 
their pharmacokinetics and pharmacodynamics (Dayton et al., 1973; Wilkinson and 21 
Shand, 1975; Wilkinson, 1987; Rowland and Tozer, 1980), other mechanisms such as 22 
alterations in plasma binding may also be involved. 23 
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 Drug molecules circulate in blood in two rapidly interchangeable forms (Daytton 1 
et al., 1973) bound to plasma proteins such as albumin, and/or α-acid glycoprotein 2 
(Wilkinson and Shand, 1975) free or unbound form (Kwong, 1985). The extent of drug 3 
binding to plasma proteins has important implications on drug disposition and drug action 4 
(Dayton et al., 1973; Wilkinson and Shand, 1975; Wilkinson, 1987; MacKichan, 1989). 5 
Drug effect often depends on the free drug in plasma, because it is this fraction of drug 6 
which can cross capillary and cell membranes and hence is an important determinant for 7 
its ability to leave the vasculature and gain access to receptors, tissues, various sites of 8 
elimination and metabolism (MacKichan, 1989). Alterations in plasma protein binding is 9 
known to effect drug disposition (Wilkinson and Shand, 1975; Wilkinson 1987; Martin, 10 
1965; Jusko and Gretch, 1976). Change in the free fraction alters hepatic elimination and 11 
distribution (Wilkinson and Shand, 1975; Wilkinson, 1987) with resulting changes in 12 
concentration at the site of action. Piperine, being highly lipophilic, could potentially 13 
effect the binding interaction of drugs to plasma proteins and hence, influence the 14 
disposition parameters of plasma bound drugs. Accordingly, we investigated the effects 15 
of piperine on the binding interaction of a number of acidic and basic drugs to plasma 16 
from healthy subjects. Additionally, we investigated the effects of piperine on the uptake 17 
of propranolol and warfarin by cultured bovine brain microvascular endothelial cells.   18 
   19 
 20 
21 
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MATERIALS AND METHODS 1 
Materials: 2 
 3 
 Diazepam, flunitrazepam, warfarin, salicylic acid, propranolol, lidocaine, 4 
antipyrine, disopyramide, phenazine and piperine were purchased from Sigma Chemical 5 
Co. (St. Louis, MO). Biodegradable scintillation fluid, acetonitrile, methyl-3H-diazepam 6 
(57 mCi/mmol), N-methyl-3H-flunitrazepam (57 mCi/mmol), 1-14C-warfarin (46 7 
mCi/mmol), DL-3H-propranolol (18  mCi/mmol), carbonyl-14C-lidocaine hydrochloride 8 
(48 mCi/mmol), were obtained from Amersham  Corp. (Arlington Heights, Ill.);  7-14C-9 
salicylic acid (58 mCi/mmol) was from Du Pont Co. (New England Nuclear Research 10 
Products, Boston, Mass.); N-methyl-14C-antipyrine (50 mCi/mmol) from ICN 11 
Radiochemicals (Irvine, CA.); and 3-14C-disopyramide (4.3 mCi/mmol) from G.D. Searle 12 
and Co. (Chicago, Ill). All radiolabelled drugs were >98% pure as determined by thin 13 
layer chromatography. Dialysis microcells and semipermeable membrane (mol. wt. cut 14 
off 12,000 to 14,000 kd; Dianorm dialyzer with spectrapor membrane No.2) were 15 
procured from Spectrum Medical Industries (Los Angeles, CA.) and Ultrasphere column 16 
(5-µm, octadecyl 25 x 4.6mm) from Beckman Instruments Inc. (Fullerton, CA). Tissue 17 
culture: dispase, deoxyribonuclease-I, rat tail collagen, fibronectin, endothelial cell 18 
growth supplement, penicillin-G, streptomycin, polymyxin-B, amphotericin-B, heparin, 19 
tris-base, were purchased from Sigma; collagenase/dispase from Boehringer-Mannheim 20 
biochemicals (Indianapolis, Ind.); Minimum essential medium (MEM),  DMEM-F12 21 
Ham nutrient mix HEPES, from Gibco laboratories (Grand Island, NY);  fetal calf serum 22 
from Hyclone Laboratories (Logan, UT); plycarbonate membranes (13mm diameter, 12-23 
µm pore size) from Nucleopore Co., (Pleasanton, Calif.); Percoll from Pharmacia LKB 24 
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Biotechnology Inc. (Piscataway, NJ); and immunohistology kit for endothelial cell 1 
characterization (Rabbit anti-factor VIII polyclonal antibodies) from Biogenex Labs. 2 
(Dublin, CA).  All other tissue culture and drug binding chemicals used were of the best 3 
available grades.          4 
 5 
Drug Binding Studies:  6 
 Blood (50ml) was collected by venepuncture into EDTA-treated tubes from 7 
healthy male subjects/volunteers (n=4) with an average age of 30±2 years and following 8 
the institutional ethical guidelines at that time. The subjects were fasted overnight and 9 
had taken no medications for at least 1 week prior to obtaining the blood sample, and 10 
were non-smokers. Plasma was obtained by centrifuging blood at 1000g for 30 min at 11 
4°C. Drug standards were added to the freshly aspirated plasma in the absence or presence 12 
of piperine (1, 10, 100 or 1000 µM)  to achieve a concentrations typical of those observed 13 
in clinical studies and as follows: diazepam, 0.1µg/ml; flunitrazepam, 0.1 µg/ml; 14 
warfarin, 1µg/ml; salicylic acid, 1µg/ml; propranolol, 0.1µg/ml; lidocaine, 3µg/ml; 15 
antipyrine, 10µg/ml and disopyramide, 10µg/ml. Each of the standard solutions contained 16 
a tracer quantity of radiolabelled drug appropriately diluted with unlabelled compound to 17 
produce the required total concentration. 18 
 19 
 Plasma binding was determined by equilibrium dialysis at 37°C using microcells 20 
and a semipermeable membrane (Mol. wt. cut-off 12,000-14,000 kd). Plasma (0.2ml) was 21 
dialysed against an equal volume of 0.067 mol/L phosphate buffer, pH 7.4 for 4 hours. 22 
The percentage of drug present in plasma in unbound form calculated using following 23 
equation: 24 
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 1 
    Drug concentration in buffer 2 
 % Unbound drug =            -----------------------------------   X 100 3 
    Drug concentration in plasma 4 
 5 
 Drug concentrations of the radiolabelled ligands was determined by liquid 6 
scintillation counting with external standardization of 50 µl of plasma or buffer added to 7 
15 ml counting scintillation fluid.  8 
 9 
 10 
Isolation and Culture of Brain Microvascular Endothelial Cells:   11 
Microvascular endothelial cells were isolated from bovine brain according to the 12 
method of Audus and Borchardt (Audus and Borchardt, 1987), with minor modifications. 13 
Briefly, the cortical tissue of two or three bovine brains obtained from the local abattoir 14 
was cleaned of mennings and all large vessels. The gray matter from the cortical region 15 
was dissected, minced, and passed through a sterile stainless steel wire mesh (1mm 16 
square), and digested for 20-30 min at 47°C with a solution of 12.5% dispase (4ml /50gm 17 
tissue) and deoxyribonuclease-I (20µg/ml) in MEM buffered with 50µM HEPES. 18 
Subsequent to this incubation, Dulbeccos’ minimal essential medium (MEM) (equal to 19 
the weight of grey matter) buffered with TRIS-base (pH 9.5) was added and the mixture 20 
further incubated for 2.5-3 hours. After digestion with dispase the cell suspension was 21 
centrifuged at 3200 rpm for 10 min and the pellet suspended in 500 ml of dextran (13%) 22 
and centrifuged at 7750 rpm for 10 min. The crude capillaries were obtained as a pellet 23 
whereas, the floating cell debris, fat, myelin was discarded. Capillary pellet was further 24 
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digested for 4hrs at 37°C with a solution of collagenase/dispase (1mg/ml) and 1 
deoxyribonuclease-I (20µg/ml). The digested suspension was centrifuged at 1000g for 10 2 
min, and the pellet suspended in 8ml MEM and 2ml aliquots of it layered over 50ml of 3 
pre-established percoll gradient and centrifuged at 3750 rpm for 10 min.  Endothelial cells 4 
were collected from the percoll and washed and suspended in complete culture medium 5 
(1:1 mixture of MEM and DMEM-F12 ham, 10mM HEPES, 13mM NaHCO3, 100 µg/ml 6 
penicillin G, 100 µg/ml streptomycin, 50µg/ml polymyxin B, 2.5µg/ml amphotericin B, 7 
100 µg/ml heparin, 25µg/ml endothelial cell growth supplement and 20% fetal calf 8 
serum). Cell viability was determined by trypan blue exclusion technique and isolated 9 
cells for later use were frozen at -70°C in complete culture medium supplemented with 10 
10% dimethyl sulfoxide.     11 
 12 
 Frozen or freshly obtained endothelial cells were thawed, suspended in complete 13 
culture medium and plated at a density of 2.5 x 106 cells/100mm in a culture dish 14 
containing polycarbonate membranes (13mm diameter). The polycarbonate filters had 15 
been fixed to the culture dish surface and coated with rat-tail collagen and fibronectin (40 16 
µg/ml), cross linked with ammonia fumes, and sterilised under UV light as described 17 
before (Audus and Borchardt, 1987). The medium was changed every day after four days 18 
of plating and the cells reached confluence in 10-12 days as determined visually under a 19 
light microscope. The purity of the cells was established morphologically and by 20 
immunofluorescent staining the cells to test for the presence of anti-Von willebrand factor 21 
VIII as described before (Audus and Borchardt, 1987) using monoclonal antibodies.  22 
 23 
Drug Uptake Studies: 24 
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 Brain microvascular endothelial cells (BMECs) play a key role in regulating 1 
transport of drugs across the blood-brain barrier. Cultured BMECs have been widely used 2 
as a model to assess the transport of drugs across BBB, in vitro, as well as uptake of drugs 3 
(Audus and Borchardt, 1987). Since free fraction of drugs is postulated to cross BBB 4 
(Dubey et al., 1989)  we used BMECs to assess the effects of piperine on drug uptake.  5 
Endothelial cells grown to confluence on polycarbonate filters were incubated with 6 
plasma containing 0.1µg/ml propranolol or 1.0µg/ml warfarin (close to clinical 7 
concentrations), and pulsed with 10.5 x 106 dpm/ml of 3H-propranolol or 15 x 106 8 
dpm/ml 14C-warfarin, in the absence or presence of 10 µM, piperine, at 37°C  for 5, 15, 9 
30, 60, and 120 seconds. Immediately after incubation the filters were washed 4 times by 10 
carefully suspending them in ice-cold phosphate buffered saline. The filters were placed 11 
in scintillation vials and treated overnight with 0.5ml of 0.3N NaOH in 1% 12 
sodiumdodecyl sulphate and drug concentrations determined by liquid scintillation 13 
counting. In separate experiments conducted in parallel, the effect of piperine on cell 14 
viability was determined by looking for trypan blue exclusion. Moreover, the loss of cells 15 
during treatment were assessed by counting the cells after trypsinization and by looking 16 
at monolayers under a light microscope after treatment. 17 
 18 
Statistical Analysis:   Differences in the plasma binding of drugs in piperine treated and 19 
untreated groups were evaluated by the paired Student’s t-test, whereas the differences in 20 
drug uptake and cell viability in treated and untreated groups was evaluated by ANOVA, 21 
utilising intergroup comparisons by Fisher´s Least Significant Difference Test (Numbers 22 
Cruncher Statistical System, Kaysville, UT). In both cases p<0.05 was taken as the 23 
minimum level of statistical significance. 24 
25 
10 
 
RESULTS 1 
 2 
Effect of Piperine on the Binding of Drugs to Human Plasma:  3 
 Piperine (Figure 1) being highly lipophilic in nature bound extensively to human 4 
plasma, with a free fraction of 0.015 ± 0.004. Pre-treatment of plasma with different 5 
concentrations of piperine significantly (p<0.01) altered the binding of both acidic and 6 
basic drugs in a concentration dependent manner (Figure 2A and 2B). In presence of 7 
piperine (100 µM) the increase in free fraction of various acidic drugs (mean ± S.D., n=4) 8 
was: 2.74±0.06 fold (p<0.01) for flunitrazepam; 3±0.16 fold (p<0.01) for diazepam; 4.69 
±0.08 (p<0.01) warfarin; 2.4±0.09 (p<0.01) salicylic acid, and for basic drugs was: 1.9±10 
0.03 fold for propranolol (p<0.01); 1.5±0.02 fold (p<0.01) for lidocaine; 1.5±0.04 fold 11 
for disopyramide (p<0.01). 12 
 13 
 There was no effect of piperine on the binding of antipyrine at any concentration. 14 
Since 100 µM piperine significantly increased the unbound fraction of all drugs, except 15 
antipyrine, we chose this concentration of piperine to assess the effects on bound to free 16 
ratio. The relative decrease in bound to free ratios of these drugs at 100 µM piperine 17 
concentration was in the order: warfarin > diazepam > flunitrazepam > salicylic acid > 18 
propranolol > lidocaine > disopyramide (Figure 3). In presence of 100 µM piperine the 19 
bound to free ratio (B/F) of albumin bound drugs (diazepam, flunitrazepam, warfarin, 20 
salicylic acid) decreased by 3.16±0.8 fold, whereas, the bound to free ratio of alpha-AGP 21 
bound drugs (propranolol, lidocaine, disopyramide) decreased by 1.65±0.05 fold (Figure 22 
3). The decrease in B/F ratio of albumin bound drugs was significantly higher (p<0.01) 23 
than those bound to α-AGP. 24 
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Effect of Piperine on Cell Viability:  1 
 Since the uptake studies were conducted for 2 min, we chose a longer i.e. 15 2 
minute period to study if the effects of piperine on drug uptake were not compromised by 3 
cell toxicity. Treatment with the highest concentration (1mM) of piperine for 15 min did 4 
not induce cell toxicity. The BMEC viability (trypan blue exclusion) in monolayers 5 
treated with vehicle or 1 mM piperne for 15 min was 99 ± 2 % and 98.5 ± 3 %, 6 
respectively (P > 0.05 vs vehicle). No floating dead cells were detected in the medium of 7 
BMEC monolayers treated for 15 min with vehicle and piperine 1mM, respectively. 8 
Moreover, the dead cell count in monolayers grown on polycarbonate filters treated with 9 
or without piperine did not differ. 10 
 11 
Effect of Piperine on Uptake of Drugs:  12 
 Piperine significantly increased the free fraction of warfarin and propranolol at a 13 
concentration of 10µM. Since free fraction of drug governs its uptake, we selected this 14 
concentration for the uptake studies using monolayers of BMECs (Figure 4A).  Uptake 15 
of propranolol and warfarin by BMECs was time dependent. In absence of piperine 16 
warfarin uptake by BMECs was significantly lower than that observed for propranolol 17 
(p<0.05). However, in the presence of 10 µM piperine the uptake of warfarin and 18 
propranolol by BMECs was significantly increased (p<0.01; Figure 4B and 4C, 19 
respectively). The increase in uptake after 60 seconds of incubation was 3.8±0.4 fold and 20 
2.1±0.04 fold, respectively. This increase in uptake was proportional to the increase in 21 
free fraction of propranolol and warfarin which in the presence of 10 µM piperine 22 
increased, from 0.229±0.05 to 0.411±0.02 for propranolol (P<.05) and from 0.009±0.003 23 
to 0.022±0.002 for warfarin (P<.05).  24 
25 
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DISCUSSION 1 
 2 
 Drug action in the body depends on the rate of absorption, distribution, 3 
metabolism and elimination (Dayton et al., 1973; Wilkinson and Shand, 1975; Wilkinson, 4 
1987; Rowland and Tozer, 1980). The pharmacological response obtained is for a 5 
majority of drugs, related to the concentration of drug at receptor site(s) (MacKichan, 6 
1989). Moreover, the binding of blood-borne endogenous or exogenous ligands to plasma 7 
constituents is an important determinant of the compounds distribution in and removal 8 
from the body (Wilkinson, 1987). The binding affinity of drugs to plasma proteins defines 9 
their ability to diffuse across the vasculature and gain access to receptors in various organs 10 
or tissues. Moreover, it governs the elimination and metabolism characteristic of a drug. 11 
Indeed, changes in a compound’s binding to plasma proteins can result in altered drug 12 
distribution and unexpected pharmacological responses (Dayton et al., 1973; Svensson et 13 
al., 1986). Plasma albumin is quantitatively the most important protein to which a large 14 
number of drugs, particularly the neutral and acidic (anionic) drugs, bind in a reversible 15 
fashion, (Sjoholm et al., 1979). Albumin contains a number of sites with differing 16 
specificities. Warfarin for example, binds with high affinity to site-I, which is also the 17 
primary binding site for bilirubin, whereas benzodiazepines and tryptophan interact more 18 
specifically with site-II. By contrast, the albumin binding of salicylic acid involves both 19 
these sites. While acidic drugs bind exclusively to albumin, drugs with basic character 20 
bind to α-acid glycoprotein more extensively, than to plasma albumin (Kwong, 1985, 21 
MacKain, 1989; Matin, 1965). Moreover, as compared to albumin, alpha-AGP contains 22 
only one binding site to which basic and some typically site-I albumin binding drugs may 23 
gain access to.   24 
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 1 
 Drug binding, can be modified by the presence of other exogenous or endogenous 2 
compounds, which can compete for the same binding sites (drug displacement by 3 
competitive inhibition). Alternatively, two ligands can be bound to two separate sites and 4 
mutually effect each other’s binding by free energy coupling between the two sites 5 
(Weber, 1975). Our observation that piperine increases the free fraction of drugs which 6 
bind to albumin (diazepam, flunitrazepam, warfarin, salicylic acid) and alpha-AGP  7 
(propranolol, lidocaine, and  disopyramide), strongly suggests that piperine binds to both 8 
albumin and alpha-AGP. Comparison of the displacing effects of piperine on the binding 9 
of both acidic and basic drugs to human plasma demonstrates that the effect is more 10 
pronounced for acidic drugs. Moreover, it suggests that piperine is more effective in 11 
displacing albumin bound drugs. A two fold difference in the bound to free ratio of 12 
warfarin (site-I) and salicylic acid (site-II) suggests a higher affinity of piperine for site-13 
I. Together, these findings suggest that piperine effectively displaces highly plasma 14 
bound drugs from both site-I and site-II of albumin and alpha-AGP. 15 
 16 
  For drugs that bind to more than one protein in plasma, significant displacement 17 
from one of the binding proteins may not result in a demonstrable change in unbound 18 
fraction and result in unaltered pharmacokinetics and pharmacodynamics. However, the 19 
observation that piperine displaces drugs, which are bound to both albumin and alpha-20 
AGP (disopyramide, propranolol, and lidocaine) suggests that piperine may also be 21 
effective in altering the pharmacokinetics and pharmacodynamics of these drugs. 22 
 23 
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 Distribution of drugs from the blood into the tissues occurs by the passage of drugs 1 
with low molecular weights (<1000) through the layer of endothelial cells of the 2 
capillaries, and binding of drugs to plasma proteins restricts the extravascular distribution 3 
of drugs (MacKichan, 1989). The observation that the uptake of propranolol and warfarin 4 
by endothelial cells was significantly increased in presence of piperine, and that there was 5 
a parallel increase in the free fraction of these drugs, suggests that the enhanced uptake 6 
of warfarin and propranolol was related to increase in free fraction of the drugs in 7 
presence of piperine. It is plausible that similar effects could occur in-vivo and result in 8 
enhanced transport, of drugs (displaced by piperine) across the biological membrane and 9 
into the tissues.  Accordingly, the displacement of alpha-AGP or albumin bound drugs by 10 
piperine might result in altered pharmacokinetics and pharmacodynamics. 11 
 12 
 Since, plasma binding is also an important determinant of the systemic clearance 13 
of a drug, with different effects depending on the free intrinsic clearance of the compound 14 
(Dayton et al., 1973; Wilkinson and Shand, 1975; Wilkinson, 1987; MacKichan, 1989). 15 
It is conceivable that displacement of drugs by piperine may also result in altered systemic 16 
clearance and therapeutic efficacy of the drug. For a poorly eliminated drug, clearance is 17 
"restricted" to the unbound moiety and an increase in this fraction results in a proportional 18 
enhancement in the clearance of total drug. Although, displacement of drugs by piperine 19 
will not affect elimination half-life of displaced drugs with moderate to large volumes of 20 
distribution, however, it may shorten the half-life of drugs with small volume of 21 
distribution. Since piperine also inhibits hepatic and intestinal drug metabolizing enzymes 22 
(Atal et al., 1985; Reen et al., 1996), it is possible that the intrinsic clearance of the drugs 23 
will decrease, and this in combination with increased free concentration of the drug may 24 
15 
 
result in sustained increase in free concentrations of displaced drugs at the site of action. 1 
Moreover, piperine induced displacement of drugs (propranolol, lidocaine) whose 2 
clearance is not limited by binding to plasma proteins "non-restrictively cleared" could 3 
result in immediate and sustained increase in unbound concentration.  This may be of 4 
clinical significance for drugs with narrow therapeutic indices and might minimally 5 
prolong the half-life of drugs with a small volume of distribution, and greatly for drugs 6 
with large volume of distribution.    7 
 8 
 The impact of alterations in protein binding on drug clearance depends on the 9 
characteristics of the drug (Dayton et al., 1973; Wilkinson and Shand, 1975; Wilkinson, 10 
1987; Rowland and Tozer, 1980). Clearance of restrictively cleared drugs is limited to 11 
free fraction of the drug and clearance of highly bound and restrictively cleared drugs are 12 
sensitive to alterations in protein binding. Hence, displacement of restrictively cleared 13 
drugs (warfarin) by piperine may result in higher free fraction, which will lead to higher 14 
clearance rates, shorter elimination half-lives and a larger fluctuation in peak and trough 15 
levels. Furthermore, a transient increase in free drug can be of sufficient magnitude to 16 
precipitate an adverse drug reaction if the drug has small volume of distribution and a 17 
narrow therapeutic index. However, in case of non-restrictively cleared drugs 18 
(propranolol, lidocaine), which are extracted by active mechanisms in both free and 19 
bound forms by the liver or the kidney, the clearance is dependent on organ blood flow 20 
and relatively independent of protein binding. Hence, alterations in free concentrations of 21 
these drugs will not be of clinical significance. 22 
 23 
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 In-vivo the efficacy of the drug not only depends on protein binding, but also 1 
greatly influenced by its metabolism. Small concentrations of several drugs reach the 2 
circulation when given orally, and are lost due metabolism "first pass effect". Piperine 3 
enhances the bioavailability of theophylline, propranolol and phenytoin in healthy 4 
volunteers (Melander, 1978; Bano et al., 1987; Bano et al., 1991) and increase the effects 5 
of hexobarbital and zoxazolamine in a reversible fashion (Atal et al., 1985). Furthermore, 6 
we previously demonstrated that the enhancement of drug bioavailability by piperine was 7 
possibly due to reversible and non-competitive inhibition of NADPH-dependent 8 
cytochrome P-450-mediated monooxygenases (Atal et al., 1985). In addition, we 9 
observed that piperine also lowers the rate glucuronidation in intestine and liver (Singh 10 
et al., 1986). Since piperine inhibits both monooxygenases and conjugases in the intestine 11 
and liver, sites where the drugs are lost due to first pass effect, it is plausible that higher 12 
concentrations of the drug will reach the circulation. However, upon reaching the 13 
circulation, the drug is bound to proteins like albumin and alpha-AGP and the delivery of 14 
the drug to the target tissue and receptor sites is restricted to the unbound fraction of the 15 
drug. Since, piperine displaces drugs from both albumin and alpha-AGP this would result 16 
in higher free concentrations of the drug and higher amounts of drug reaching the target 17 
tissues and receptors or even increased elimination or clearance of the administered drug. 18 
Hence, piperine could potentially alter the pharmacokinetics and pharmacodynamics of 19 
drugs irrespective of the route of administration.  20 
  21 
 Although, our findings provide evidence that piperine reduces drug binding to 22 
plasma proteins and increases their uptake by BMECs in vitro, it has limitations. First, 23 
whether piperine influences drug binding in vivo and whether this is associated with 24 
17 
 
enhanced drug bioavailability is unknown. Second, piperine binds reversibly to serum 1 
albumin by hydrophobic interactions with a binding constant of 104Mol/L and a 2 
stoichiometry of 1:1 preferably at the binding site of subdomain I-B. Even though binding 3 
constant of piperine with serum albumin is moderate, major portion of the piperine in 4 
blood circulation may still be in the bound form because of very high physiological 5 
concentration of albumin (0.6 mM). Based on these characteristics, whether piperine can 6 
compete with other drugs for the binding site on serum albumins and consequently make 7 
the drugs available in the un-bound form remains unknown and can only be speculated. 8 
Third, the serum levels of piperine following oral or intraperitoneal administration are 9 
0.15% of the dose administered, moreover significant presence of piperine metabolite in 10 
serum have been reported (Srinivasan 2007; Suresh and Srinivasan 2010;  Bajad et al., 11 
2003). Whether circulating concentrations of piperine and its metabolite can influence 12 
drug binding in vivo remains unknown.  Finally, the fact that piperine increases the uptake 13 
in BMECs suggests that it may facilitate transport of drugs across the blood-brain barrier. 14 
However, in vivo brain-uptake index studies are required to confirm this possibility. 15 
 16 
 In conclusion, piperine significantly decreases the binding of both acidic and basic 17 
drugs to human plasma and increases the uptake of warfarin and propranolol by BMECs. 18 
The findings that piperine inhibits drug metabolism as well as increases the free fraction 19 
of plasma bound drugs, suggests that piperine can potentially alter the pharmacokinetics 20 
and pharmacodynamics of drugs irrespective of the route of administration. Moreover, 21 
piperine may be useful in modulating the effects of clinically used drugs and this 22 
possibility needs further investigation. 23 
  24 
18 
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alpha-AGP; free fraction, fu; Dulbeccos’ minimum essential medium, MEM 2 
 3 
Acknowledgements: We thank Dr. Grant R. Wilkinson (deceased), Department of 4 
Pharmacology, Center for Clinical Pharmacology, Vanderbilt University, Nashville, TN, 5 
for providing the support to conduct these studies.  6 
 7 
Source(s) of Funding:  None 8 
 9 
Conflict of Interest/Disclosure(s): None 10 
 11 
 12 
 13 
19 
 
REFERENCES 1 
 2 
Atal CK, Dubey RK, Singh J. 1985. Biochemical evidence of enhanced drug 3 
bioavailability by piperine: evidence that piperine is a potent inhibitor of drug 4 
metabolism.  J Pharmacol Exp Ther 232: 258-262. 5 
 6 
Audus KL, Borchardt RT. 1987. Bovine brain microvessel endothelial cell monolayers 7 
as a model system for the blood brain barrier. Ann N Y Acad Sci 507: 9-18. 8 
 9 
Bajad S, Bedi KL, Singla AK, Johri RK. 2001. Piperine inhibits gastric emptying and 10 
gastrointestinal transit in rats and mice. Planta Med 67: 176-179. 11 
 12 
Bano G, Amla V, Raina RK, Zutshi U, Chopra CL. 1987. The effect of piperine on 13 
pharmacokinetics of phenytoin in healthy volunteers. Planta Med 53: 568-569. 14 
 15 
Bano G, Raina RK, Zutshi U, Bedi KL, Johri RK, Sharma SC. 1987. Effect of piperine 16 
on bioavailability and pharmacokinetics of propranolol and theophylline in healthy 17 
volunteers.  Eur J Clin Pharmacol 41: 615-617. 18 
 19 
Belada SK, Boga PK. 2017. The influence of piperine on the pharmacokinetics of 20 
fexofenadine, a P-glycoprotein substrate, in healthy volunteers. Eur J Clin Pharmacol. 21 
73: 343-349.  22 
 23 
20 
 
Dayton PG, Israili ZH, Perel JM. 1973. Influence of binding on drug metabolism and 1 
distribution. Ann NY Acad Sci 226: 172-194. 2 
 3 
Dubey RK, McAllister CB, Inoue M, Wilkinson GR. 1989. Plasma binding and 4 
transport of diazepam across blood-brain barrier. No evidence for in vivo enhanced 5 
dissociation. J Clin Invest 84: 1155-1159. 6 
 7 
Jin M-J, Han H-K. 2010. Effect of piperine, a major component of black pepper, on 8 
intestinal absorption of fexofenadine and its implication on food-drug interaction. J 9 
Food Sci 75: H93-H96.  10 
 11 
Jusko WJ, Gretch M. 1976. Plasma and tissue protein binding of drugs in 12 
pharmacokinetics. Drug Metab Rev 5: 43-140. 13 
 14 
Kwong TC. 1985. Free drug measurements: methodology and clinical significance. 15 
Clinica Chimica Acta. 151: 193-216. 16 
 17 
MacKichan JJ 1989. Protein binding drug displacement interactions fact or fiction. Clin 18 
Pharmacokin 16: 65-73. 19 
 20 
Martin BK. 1965. Potential effect of the plasma on drug distribution. Nature 207: 274-21 
276. 22 
 23 
Melander A. 1978. Influence of food on bioavailability. Clin Pharmacokin 3: 337-351. 24 
21 
 
 1 
Reen RK, Roesch SF, Kiefer F, Wiebel FJ, Singh J. 1996. Piperine impairs cytochrome 2 
P4501A1 activity by direct interaction with the enzyme and not by down regulation of 3 
CYP1A1 gene expression in the rat hepatoma 5L cell line. Biochem Biophys Res 4 
Commun 218: 562-569. 5 
 6 
Rowland M, Tozer TN. 1980. Clinical Pharmacokinetics. Concepts and Application, 7 
Lea and Febiger Press, Philadelphia. 8 
 9 
Singh J, Dubey RK, Atal CK. 1986. Piperine-mediated inhibition of glucuronidation 10 
activity in isolated epithelial cells of the guinea-pig small intestine: evidence that 11 
piperine lowers the endogenous UDP-glucuronic acid content. J Pharmacol Exp Therap 12 
236: 488-493. 13 
 14 
Sjöholm I, Ekman B, Kober A, Ljungstedt-Pählmän I, Seiving B, Sjodin T. 1979. 15 
Binding of drugs to human serum albumin XI: The specificity of three binding sites as 16 
studied with albumin immobilized in microparticles. Mol Pharmacol 16: 767-777. 17 
 18 
Sotaniemi EA 1973: Effects of drug pretreatment on antipyrine levels in blood and 19 
tissues: an example of multiple drug interactions. Pharmacology 10: 306-316. 20 
 21 
Srinivasan K. 2007. Black pepper and its pungent principle-piperine: A review of 22 
diverse physiological effects. Crtic Rev Food Sci Nutr 47: 735-748. 23 
 24 
22 
 
Suresh DV, Mahesha HG, Rao AGA, Srinivasan K. 2007. Binding of bioactive 1 
phytochemical piperine with human serum albumin: A spectrofluorometric study. 2 
Biopolymers 86: 265-275. 3 
 4 
Suresh D, Srinivasan K. 2010. Tissue distribution & elimination of capsaicin & 5 
curcumin following oral intake in rats. Ind J Med Res 131: 682-691. 6 
 7 
Svensson CK, Woodruff  MN, Baxter JG, Lalka D. 1986. Free drug concentration 8 
monitoring in clinical practice. Rationale and current status. Clin Pharmacokin. 11: 9 
450-469. 10 
 11 
Weber G. 1975. Energetics of ligand binding proteins. Adv Prot Chem 29: 1-83. 12 
 13 
Wilkinson GR, Shand DG. 1975. Commentary: a physiological approach to hepatic 14 
drug clearance. Clin Pharmacol Ther 18: 377-390. 15 
 16 
Wilkinson G.R. 1987. Clearance approaches in pharmacology.  Pharmacol Rev 39: 1-17 
47. 18 
 19 
Zutshi RK, Singh R, Zutshi U, Johri RK, Atal CK. 1985. Influence of piperine on 20 
rifampicin blood levels in patients of pulmonary tuberculosis. J Assoc Physicians Ind 21 
330: 223-224. 22 
  23 
24 
23 
 
Figure Legends: 1 
 2 
Figure 1: Chemical structure of piperine. 3 
 4 
Figure 2:  Bar graph depicting the concentration-dependent effects of piperine (1, 10, 5 
100, 1000 µM) on the binding of: (A) salicylic acid, diazepam, warfarin and lidocaine; 6 
and (B) propranolol, flunitrazepam, disopyramide and antipyrine, to human plasma. 7 
Results (mean±S.D.) express changes in the unbound free fraction (fu) of the drug in 8 
presence or absence of piperine (n=4). * represents P<0.05 versus samples treated with 9 
vehicle alone. 10 
 11 
Figure 3:  Bar graph comparing the effects of piperine (100 µM) on the bound/free ratio 12 
of (A) alpha-AGP bound drugs (propranolol [PRL], lidocaine [LDC], disopyramide 13 
[DPY]) and  (B) albumin bound drugs (diazepam [DZP], flunitrazepam [FNZ], warfarin 14 
[WRF], salicylic acid [SA], to human plasma. Results are expresssed as mean±S.D.( n=4). 15 
* represents P<0.05 versus samples treated with vehicle alone. 16 
 17 
Figure 4: Panel A depicts a representative photomicrograph of a confluent monolayer of 18 
brain microvascular endothelial cells used for drug uptake studies. Panel B depicts a line 19 
graph showing the effects of piperine (10 µM) on the time-dependent uptake of plasma 20 
bound 14C-warfarin by bovine brain microvascular endothelial cells. Values at each point 21 
represents mean±S.D. (n=4) and expressed as disintegration per minute (dpm)/17.7x104 22 
endothelial cells. * represents P<0.05 versus samples treated with vehicle alone. Panel C 23 
depicts a line graph showing the effects of piperine (10 µM) on the time-dependent 24 
24 
 
uptake of plasma bound 3H-propranolol by bovine brain microvascular endothelial cells. 1 
Values at each point represents mean ± S.D. (n=4) and expressed as disintegration per 2 
minute (dpm)/17.7x104 endothelial cells. * represents P<0.05 versus samples treated with 3 
vehicle alone. 4 
 5 




